Music Therapy Combined with Virtual Reality Reduces Prevalent Symptoms in Adult Patients with Advanced Cancer: Randomized Clinical Trial
Iturri A, Bertella A, Dóvidas MN, Spector J, Alonso Babarro A
Journal of palliative medicine · 1 cita
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2026-01-09 · J Palliat Med · vol. 29 · número 5 · págs. 594–601
- Editorial
- Mary Ann Liebert, Inc.
- Citado
- 0 citas · más que el 2% de estudios similares · 0.0× el promedio de su campo
- Referencias
- 19 trabajos
- Acceso
- De pago
- Áreas de investigación
- Music Therapy and Health · Palliative and Oncologic Care · Palliative Care and End-of-Life Issues
- Palabras clave
- music therapy, virtual reality, advanced cancer, palliative care, symptom management, anxiety, emotional distress, heart rate, patient experience, transcendental experience, Edmonton Symptom Assessment System
- MeSH
- humans, neoplasms, music therapy, palliative care, anxiety, adult, aged, aged, 80 and over, middle aged, argentina, female, male, virtual reality
5 autores
- Agustina Iturri🇦🇷Austral University; Hospital Universitario Austral
- María Adela Bertella🇦🇷Austral University
- Marcelo Nicolás Dóvidas🇦🇷National Technological University
- Javier Spector🇦🇷Austral University
- Alberto Alonso Babarro🇪🇸Hospital Universitario La Paz
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Music therapy (MT) and virtual reality (VR) are increasingly being used in palliative care for symptom management, though evidence quality remains low.
Objectives
The aim of our study was to assess the effect of combined MT + VR on the main symptom in palliative cancer patients.
Design
This study employed an explanatory sequential mixed methods design based on a randomized controlled clinical trial, integrating quantitative outcomes with qualitative patient experiences.
Measurements
The main symptom was the symptom rated as most severe by the patient on the Edmonton Symptom Assessment System Revised (ESAS-r) scale. Secondary outcomes included the global ESAS-r score, anxiety (additionally measured with State-Trait Anxiety Inventory-State [STAI-S]), emotional distress (DME scale), and heart rate. All variables were assessed at three time points: baseline (T1), post-intervention (T2), and 24 hours post-intervention (T3).
Patients and settings
Adult patients attended by palliative care with advanced cancer at a university hospital in Argentina.
Results
Sixty patients completed the protocol. Significant differences between baseline (T1) and immediate post-intervention (T2) were observed when comparing the MT + VR condition to the control group for the main symptom (1.5 vs. 0, p p p < 0.001). No significant differences were found between groups at 24 hours post-intervention (T3) compared with baseline. Several categories of interest emerged: (a) affective states, (b) projections, and (c) transcendental experiences.
Conclusion
The combination of MT + VR improved the main symptom, as compared with the control group. Patient perceptions add valuable information about the factors that influenced this difference.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.